Home Immunai

Immunai

In operation
Series B
Biotechnology R&D Developer

Basic Information

Immunai is a biotechnology company with state-of-the-art genomic technology and machine learning capabilities, aiming to uncover the immune system. Immunai uses single-cell biology and AI to comprehensively map the immune system to drive new therapeutic discovery, accelerate drug development, and improve patient outcomes.
Immunai Inc.
NewYork,NewYork,United States of America
15~50 people
January 01, 2019
info@immunai.com